Dose levels outside radiotherapy beams

The British Journal of Radiology
D GreeneD W Thomas

Abstract

The specification of a radiotherapy generator calls for the leakage radiation through the housing of the source to be 0.1% (the ICRP has recently (1982) changed this figure to 0.2% of the dose rate inside the useful beam). When a patient is irradiated, the dose level outside the useful beam is not only determined by this leakage radiation, but also by scattered radiation from the beam-defining system and from the treatment volume of the patient. Measurements have been made on a 300 kV X-ray unit, and on two different 4 MV and one 8 MV linear accelerators to determine the levels of leakage radiation and scattered radiation in air, and in a phantom comparable in size to the trunk of the patient. Similar measurements have also been made for a 15 MeV neutron generator. It is shown that for all these generators the dose delivered outside the radiation beam is determined mainly by the two scattering processes mentioned, and it is argued that for linear accelerators it would be feasible to increase the permitted level of leakage radiation by a factor of 2 or 3 without a significant increase in the stray radiation delivered to the patient.

References

Jan 1, 1979·Physics in Medicine and Biology·D Greene, I Rosenberg
Sep 1, 1978·Physics in Medicine and Biology·V E Lewis, J B Hunt
May 1, 1974·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Greene, D Major
Sep 1, 1971·The British Journal of Radiology·D A Lundberg
Aug 1, 1983·The British Journal of Radiology·F ChenM Bianchi
Jul 1, 1958·Physics in Medicine and Biology·S B OSBORN, R G BURROWS

❮ Previous
Next ❯

Citations

Mar 6, 2004·Medical Physics·Robin L SternZelanna Goldberg
Oct 27, 1998·International Journal of Radiation Oncology, Biology, Physics·G StevensA Ralston
Aug 1, 1983·The British Journal of Radiology·F ChenM Bianchi
May 1, 1985·The British Journal of Radiology·D GreeneR J Taylor
May 1, 1985·The British Journal of Radiology·R E Hutchings
Apr 1, 1990·The British Journal of Radiology·B J McParland
Mar 1, 1984·The British Journal of Radiology·F R HudsonM Samarasekara
Jun 10, 2008·Physics in Medicine and Biology·X George XuHarald Paganetti
Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·P H Van der Giessen
Mar 1, 1997·International Journal of Radiation Oncology, Biology, Physics·A Niroomand-RadK W Harter
Feb 13, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L CozziA Fogliata
Jul 1, 1997·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·J CyglerP Cross
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J Y TingP V Houdek
Dec 1, 1994·International Journal of Radiation Oncology, Biology, Physics·P H van der Giessen
Mar 1, 1985·International Journal of Radiation Oncology, Biology, Physics·B A FraassA S Lichter
Mar 1, 1985·International Journal of Radiation Oncology, Biology, Physics·B A FraassE Glatstein
Dec 1, 1985·International Journal of Radiation Oncology, Biology, Physics·S Sherazi, K R Kase
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·D De RuysscherE van der Schueren
Sep 24, 2004·International Journal of Radiation Oncology, Biology, Physics·Marilyn StovallJohn D Boice
Jan 27, 2015·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Etieli C da CostaDelano Valdivino S Batista
Sep 30, 1993·International Journal of Radiation Oncology, Biology, Physics·M L FooE G Shaw
Jan 5, 2002·Physics in Medicine and Biology·Y MejaddemA Brahme
Jan 25, 2017·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Jérémi Vũ BezinIbrahima Diallo
Nov 3, 2021·Biomedical Physics & Engineering Express·Ghazale GerailyAmir Hossein Karimi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.